[HTML][HTML] CRISPER/CAS system, a novel tool of targeted therapy of drug-resistant lung cancer
VA Kordkheyli, M Rashidi, Y Shokri… - Advanced …, 2022 - ncbi.nlm.nih.gov
Lung cancer (LC) is the most common cause of cancer-related death worldwide. Patients
with LC are usually diagnosed at advanced phases. Five-year survival rate in LC patients is …
with LC are usually diagnosed at advanced phases. Five-year survival rate in LC patients is …